Literature DB >> 6387483

Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia).

G B Bolli, I S Gottesman, P J Campbell, M W Haymond, P E Cryer, J E Gerich.   

Abstract

To determine the roles of glucose counterregulation and the waning of insulin action in the development of posthypoglycemic hyperglycemia (the Somogyi phenomenon), we studied changes in plasma glucose and glucose turnover in five patients with insulin-dependent diabetes mellitus (IDDM) after subcutaneous injection of insulin under conditions in which hypoglycemic glucose counterregulation and the waning of insulin action were allowed to occur or were prevented. In control experiments, in which both glucose counterregulation and insulin waning were allowed to occur, plasma glucose levels decreased from 94 +/- 3 to 47 +/- 7 mg per deciliter and then increased to 289 +/- 20 mg per deciliter at 12 hours because of a marked increase in glucose production. When the waning of insulin action was prevented by insulin infusion, glucose production increased less (P less than 0.01), but marked rebound hyperglycemia still occurred (188 +/- 26 mg per deciliter at 12 hours). When both insulin waning and glucose counterregulation were prevented by infusion of both glucose and insulin, glucose production did not increase, and rebound hyperglycemia did not occur. We conclude that hypoglycemia can cause rebound hyperglycemia in the absence of insulin waning in patients with IDDM, and that this results primarily from an excessive increase in glucose production due to activation of glucose counterregulatory systems.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387483     DOI: 10.1056/NEJM198411083111904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  19 in total

1.  Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.

Authors:  S Attvall; J Fowelin; H von Schenck; I Lager; U Smith
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

2.  Transient insulin resistance following infusion of adrenaline in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M Kollind; U Adamson; P E Lins; B Hamberger
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

3.  Hypoglycemia impairs quality of blood glucose simulation in a clinical decision support system.

Authors:  Mette Dencker Johansen; Ole K Hejlesen; David A Cavan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

4.  Cognitive function during hypoglycaemia in type I diabetes mellitus.

Authors:  S Pramming; B Thorsteinsson; A Theilgaard; E M Pinner; C Binder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

Review 5.  The physiological basis of insulin treatment--clinical aspects.

Authors:  W K Waldhäusl
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

6.  Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin.

Authors:  P C Lyn
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

Review 7.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

8.  Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.

Authors:  Paola Lucidi; Paolo Rossetti; Francesca Porcellati; Simone Pampanelli; Paola Candeloro; Anna Marinelli Andreoli; Gabriele Perriello; Geremia B Bolli; Carmine G Fanelli
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

Review 9.  Insulin-dependent (type I) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

10.  Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans.

Authors:  C Fanelli; A Di Vincenzo; F Modarelli; M Lepore; M Ciofetta; L Epifano; S Pampanelli; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.